Hence, downregulation of VEGF protein levels has become a goal of novel RNAi therapies, as shown in the recently developed ALL-VSP formulation of systematically-derived siRNA targeting VEGF and KSP (Kinesin spindle protein) [201]. Here, VEGFA is linked to acute lymphoblastic leukemia.